For those companies that must, as a condition of doing business, meet the challenges inherent in regulatory compliance, deploying a validated environment is a costly investment (but also a necessary requirement). Compliance ought not to be a capital concern, but rather an operational expenditure.  Business functions within these companies are currently realizing substantial savings by switching over to a rent-versus-buy model. Unfortunately, until recently, compliance-bound Pharmaceutical, Biotechnology, and Medical Device companies were forced to purchase (and house) hardware and acquire software licenses while amortizing that investment over a number of years. The quality, validation, and GxP complications through which the Research and Development, Compliance, and Manufacturing divisions must work has made it difficult for those business units to experience the savings associated with a fully managed off-site hosted solution.